1. Table of Contents
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Myasthenia Gravis Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Myasthenia Gravis Clinical Trials by Region
2.2.2 Average Enrollment of Myasthenia Gravis Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Myasthenia Gravis Treatment, 2019

3. Region wise Myasthenia Gravis Clinical Trials
3.1 Asia Pacific Myasthenia Gravis Clinical Trials by Country
3.2 Europe Myasthenia Gravis Clinical Trials by Country
3.3 North America Myasthenia Gravis Clinical Trials by Country
3.4 Middle East and Africa Myasthenia Gravis Clinical Trials by Country
3.5 South and Central America Myasthenia Gravis Clinical Trials by Country

4. Myasthenia Gravis Clinical Trial Trends
4.1 Start Year wise Myasthenia Gravis Clinical Trials
4.2 Phase wise Myasthenia Gravis Clinical Trials
4.3 Trial Status wise Myasthenia Gravis Clinical Trials
4.4 Trial Type wise Myasthenia Gravis Clinical Trials

5. Myasthenia Gravis Average Enrollment Trends
5.1 Average Enrollment in Myasthenia Gravis Trials by Year
5.2 Average Enrollment in Myasthenia Gravis Trials by Phase
5.3 Average Enrollment in Myasthenia Gravis Trials by Status
5.4 Average Enrollment in Myasthenia Gravis Trials by Type of Trial

6. Companies Participating in Myasthenia Gravis Clinical Trials
6.1 Myasthenia Gravis Trials by Sponsor Type
6.2 Myasthenia Gravis Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Myasthenia Gravis Trials- Phase 1
7.2 Myasthenia Gravis Trials- Phase 2
7.3 Myasthenia Gravis Trials- Phase 3
7.4 Myasthenia Gravis Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Myasthenia Gravis Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Myasthenia Gravis Clinical Trials and Enrolment
Figure 5: Europe – Country wise Myasthenia Gravis Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Myasthenia Gravis Clinical Trials and Enrolment
Figure 7: North America – Country wise Myasthenia Gravis Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Myasthenia Gravis Clinical Trials and Enrolment
Figure 9: Myasthenia Gravis Clinical Trials by Phase
Figure 10: Myasthenia Gravis Clinical Trials by Trial Status
Figure 11: Myasthenia Gravis Clinical Trials by Type
Figure 12: Myasthenia Gravis Clinical Trials by Sponsor Type
Figure 13: Myasthenia Gravis Clinical Trials by Leading Sponsors
Figure 14: Myasthenia Gravis Average Enrollment by Phase
Figure 15: Myasthenia Gravis Average Enrollment by Trial Status
Figure 16: Myasthenia Gravis Average Enrollment by Type
Figure 17: Myasthenia Gravis- Average Enrolment by Type of Sponsors
Figure 18: Myasthenia Gravis- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List of Tables
Table 1: Myasthenia Gravis Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Myasthenia Gravis Clinical Trials and Enrolment
Table 5: Europe – Country wise Myasthenia Gravis Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Myasthenia Gravis Clinical Trials and Enrolment
Table 7: North America – Country wise Myasthenia Gravis Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Myasthenia Gravis Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Myasthenia Gravis Average Enrollment by Phase
Table 15: Myasthenia Gravis Average Enrollment by Trial Status
Table 16: Myasthenia Gravis Average Enrollment by Type
Table 17: Myasthenia Gravis- Average Enrolment by Type of Sponsors
Table 18: Myasthenia Gravis- Enrolment by Leading Sponsors

Companies mentioned
Accutest Research Laboratories India Pvt Ltd, Alexion Pharmaceuticals Inc, Amarin Corp Plc, Astellas Pharma Inc, Clindev Global Inc, CSL Ltd, CuraVac Inc, Cytokinetics Inc, F. Hoffmann-La Roche Ltd, Quintiles IMS Holdings Inc